Boutron, Isabelle

Peer reviewers identified spin in manuscripts of nonrandomized studies assessing therapeutic interventions, but their impact on spin in abstract conclusions was limited

Lazarus, C., Haneef, R., Ravaud, P., Hopewell, S., Altman, D. G., & Boutron, I. (2016) · Journal of Clinical Epidemiology

Meta-analysis and systematic reviewsAcademic Publishing and Open Access

Cited by 58

Changes in evidence for studies assessing interventions for COVID-19 reported in preprints: meta-research study

the COVID-19 NMA Consortium, Oikonomidi, T., Boutron, I., Pierre, O., Cabanac, G., & Ravaud, P. (2020) · BMC Medicine

Academic Publishing and Open AccessMeta-analysis and systematic reviews

Cited by 54

Reporting of Harm in Randomized, Controlled Trials of Nonpharmacologic Treatment for Rheumatic Disease

Ethgen, M., Boutron, I., Baron, G., Giraudeau, B., Sibilia, J., & Ravaud, P. (2005) · Annals of Internal Medicine

Meta-analysis and systematic reviewsStatistical Methods in Clinical Trials

Cited by 49

The use of clinical study reports to enhance the quality of systematic reviews: a survey of systematic review authors

Hodkinson, A., Dietz, K. C., Lefebvre, C., Golder, S., Jones, M., Doshi, P., Heneghan, C., Jefferson, T., Boutron, I., & Stewart, L. (2018) · Systematic Reviews

Meta-analysis and systematic reviewsPharmaceutical industry and healthcare

Cited by 49

Reminding Peer Reviewers of Reporting Guideline Items to Improve Completeness in Published Articles: Primary Results of 2 Randomized Trials

Speich, B., Mann, E., Schönenberger, C. M., Mellor, K., Griessbach, A. N., Dhiman, P., Gandhi, P., Lohner, S., Agarwal, A., Odutayo, A., et al. (2023) · JAMA Network Open

Meta-analysis and systematic reviewsAcademic Publishing and Open Access

Cited by 41

Interventions for the prevention and treatment of COVID-19: a living mapping of research and living network meta-analysis

Boutron, I., Chaimani, A., Devane, D., Meerpohl, J. J., Rada, G., Hróbjartsson, A., Tovey, D., Grasselli, G., & Ravaud, P. (2020) · Cochrane Database of Systematic Reviews

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

Cited by 41

Reporting of analyses from randomized controlled trials with multiple arms: a systematic review

Baron, G., Perrodeau, E., Boutron, I., & Ravaud, P. (2013) · BMC Medicine

Meta-analysis and systematic reviewsStatistical Methods in Clinical Trials

Cited by 39

Influence and management of conflicts of interest in randomised clinical trials: qualitative interview study

Østengaard, L., Lundh, A., Tjørnhøj-Thomsen, T., Abdi, S., Gelle, M. H. A., Stewart, L. A., Boutron, I., & Hróbjartsson, A. (2020) · BMJ

Pharmaceutical industry and healthcareEthics in Clinical Research

Cited by 35

Impact of a short version of the CONSORT checklist for peer reviewers to improve the reporting of randomised controlled trials published in biomedical journals: study protocol for a randomised controlled trial

Speich, B., Schroter, S., Briel, M., Moher, D., Puebla, I., Clark, A., Maia Schlüssel, M., Ravaud, P., Boutron, I., & Hopewell, S. (2020) · BMJ Open

Meta-analysis and systematic reviewsAcademic Publishing and Open Access

Cited by 35

Transparency and reporting characteristics of COVID-19 randomized controlled trials

Kapp, P., Esmail, L., Ghosn, L., Ravaud, P., & Boutron, I. (2022) · BMC Medicine

Academic Publishing and Open AccessMeta-analysis and systematic reviews

Cited by 25

Consolidated Standards of Reporting Trials (CONSORT) extensions covered most types of randomized controlled trials, but the potential workload for authors was high

Ghosn, L., Boutron, I., & Ravaud, P. (2019) · Journal of Clinical Epidemiology

Meta-analysis and systematic reviewsStatistical Methods in Clinical Trials

Cited by 24

A scoping review identifies multiple comments suggesting modifications to SPIRIT 2013 and CONSORT 2010

Nejstgaard, C. H., Boutron, I., Chan, A.-W., Chow, R., Hopewell, S., Masalkhi, M., Moher, D., Schulz, K. F., Shlobin, N. A., Østengaard, L., et al. (2023) · Journal of Clinical Epidemiology

Meta-analysis and systematic reviewsStatistical Methods in Clinical Trials

Cited by 21

Selective primary outcome reporting in high-impact journals of anaesthesia and pain

Bonnot, B., Yavchitz, A., Mantz, J., Paugam-Burtz, C., & Boutron, I. (2016) · British Journal of Anaesthesia

Meta-analysis and systematic reviewsStatistical Methods in Clinical Trials

Cited by 17

Patients’ Perspectives on Transforming Clinical Trial Participation: Large Online Vignette-based Survey.

Nguyen, V. T., Ravaud, P., Tran, V. T., Young, B., & Boutron, I. (2022) · Journal of Medical Internet Research

Ethics in Clinical ResearchStatistical Methods in Clinical Trials

Cited by 17

Sharing of Individual Patient-Level Data by Trialists of Randomized Clinical Trials of Pharmacological Treatments for COVID-19

Esmail, L. C., Kapp, P., Assi, R., Wood, J., Regan, G., Ravaud, P., & Boutron, I. (2023) · JAMA

Research Data Management PracticesAcademic Publishing and Open Access

Cited by 16

Development of a topic‐specific bibliographic database supporting the updates of SPIRIT 2013 and CONSORT 2010

Østengaard, L., Barrientos, A., Boutron, I., Chan, A., Collins, G., Hopewell, S., Moher, D., Nejstgaard, C. H., Schulz, K. F., Speich, B., et al. (2024) · Cochrane Evidence Synthesis and Methods

Meta-analysis and systematic reviewsClinical practice guidelines implementation

Cited by 15

Methodological issues in trials assessing primary prophylaxis of venous thrombo-embolism

Thabut, G., Estellat, C., Boutron, I., Samama, C. M., & Ravaud, P. (2006) · European Heart Journal

Venous Thromboembolism Diagnosis and ManagementStatistical Methods in Clinical Trials

Cited by 11

Impact of adding a limitations section to abstracts of systematic reviews on readers’ interpretation: a randomized controlled trial

Yavchitz, A., Ravaud, P., Hopewell, S., Baron, G., & Boutron, I. (2014) · BMC Medical Research Methodology

Meta-analysis and systematic reviewsAcademic Publishing and Open Access

Cited by 11

Trial analysis by treatment allocated or by treatment received? Origins of ‘the intention-to-treat principle’ to reduce allocation bias: Part 2

Chalmers, I., Matthews, R., Glasziou, P., Boutron, I., & Armitage, P. (2023) · Journal of the Royal Society of Medicine

Statistical Methods in Clinical TrialsHistorical Medical Research and Treatments

Cited by 9

Comparison of effect estimates between preprints and peer-reviewed journal articles of COVID-19 trials

Davidson, M., Evrenoglou, T., Graña, C., Chaimani, A., & Boutron, I. (2024) · BMC Medical Research Methodology

Academic Publishing and Open AccessMeta-analysis and systematic reviews

Cited by 9

No evidence of important difference in summary treatment effects between COVID-19 preprints and peer-reviewed publications: a meta-epidemiological study

Davidson, M., Evrenoglou, T., Graña, C., Chaimani, A., & Boutron, I. (2023) · Journal of Clinical Epidemiology

Academic Publishing and Open AccessMeta-analysis and systematic reviews

Cited by 8

Trial analysis by treatment allocated or by treatment received? Origins of ‘the intention-to-treat principle’ to reduce allocation bias: Part 1

Chalmers, I., Matthews, R., Glasziou, P., Boutron, I., & Armitage, P. (2023) · Journal of the Royal Society of Medicine

Statistical Methods in Clinical TrialsAdvanced Causal Inference Techniques

Cited by 7

Dissemination of 2014 dual antiplatelet therapy (DAPT) trial results: a systematic review of scholarly and media attention over 7 months

Sharp, M. K., Haneef, R., Ravaud, P., & Boutron, I. (2017) · BMJ Open

Academic Publishing and Open AccessMeta-analysis and systematic reviews

Cited by 1